Brief Description
EZNome commercializes high-throughput mammalian genome editing technologies utilizing CRISPR ribonucleoprotein (RNP) electroporation of zygotes (CRISPR-EZ).
Timeline
- 2018. Company founded.
Inventors
Sean Chen, Lin He, Yiu-Fai Lee
EZNome, Inc.